ID16091A - Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida - Google Patents
Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamidaInfo
- Publication number
- ID16091A ID16091A IDP970478A ID970478A ID16091A ID 16091 A ID16091 A ID 16091A ID P970478 A IDP970478 A ID P970478A ID 970478 A ID970478 A ID 970478A ID 16091 A ID16091 A ID 16091A
- Authority
- ID
- Indonesia
- Prior art keywords
- carbon atom
- amino
- configuration
- pheniletanolaminotetralin
- carboxamide
- Prior art date
Links
- 150000003857 carboxamides Chemical class 0.000 title 1
- 238000006467 substitution reaction Methods 0.000 title 1
- 229910052799 carbon Inorganic materials 0.000 abstract 4
- 125000004432 carbon atom Chemical group C* 0.000 abstract 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 206010000242 Abortion threatened Diseases 0.000 abstract 1
- 208000005107 Premature Birth Diseases 0.000 abstract 1
- 206010036590 Premature baby Diseases 0.000 abstract 1
- 208000005985 Threatened Abortion Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 102000016966 beta-2 Adrenergic Receptors Human genes 0.000 abstract 1
- 108010014499 beta-2 Adrenergic Receptors Proteins 0.000 abstract 1
- 229940124630 bronchodilator Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 201000011086 ureterolithiasis Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/04—Drugs for disorders of the urinary system for urolithiasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP6888596 | 1996-02-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID16091A true ID16091A (id) | 1997-09-04 |
Family
ID=13386565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDP970478A ID16091A (id) | 1996-02-19 | 1997-02-19 | Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6133266A (cs) |
| EP (1) | EP0882704B1 (cs) |
| JP (1) | JP3892045B2 (cs) |
| KR (1) | KR100491633B1 (cs) |
| CN (1) | CN1100032C (cs) |
| AT (1) | ATE225767T1 (cs) |
| AU (1) | AU725042B2 (cs) |
| BR (1) | BR9707566B1 (cs) |
| CA (1) | CA2245490C (cs) |
| CZ (1) | CZ293974B6 (cs) |
| DE (1) | DE69716242T2 (cs) |
| DK (1) | DK0882704T3 (cs) |
| EA (1) | EA002143B1 (cs) |
| ES (1) | ES2184989T3 (cs) |
| HU (1) | HU229400B1 (cs) |
| ID (1) | ID16091A (cs) |
| MY (1) | MY123853A (cs) |
| NO (1) | NO323095B1 (cs) |
| NZ (1) | NZ331445A (cs) |
| PL (1) | PL186411B1 (cs) |
| PT (1) | PT882704E (cs) |
| SG (1) | SG72727A1 (cs) |
| TW (1) | TW375604B (cs) |
| WO (1) | WO1997030023A1 (cs) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999009001A1 (fr) * | 1997-08-19 | 1999-02-25 | Kissei Pharmaceutical Co., Ltd. | Derives de phenylethanolaminotetraline et bronchodilatateurs |
| ZA994264B (en) | 1998-07-01 | 2000-01-25 | Warner Lambert Co | Stereoisomers with high affinity for adrenergic receptors. |
| GB9913083D0 (en) * | 1999-06-04 | 1999-08-04 | Novartis Ag | Organic compounds |
| US7232837B2 (en) | 1999-06-29 | 2007-06-19 | Mcneil-Ppc, Inc. | Stereoisomers with high affinity for adrenergic receptors |
| FR2809725B1 (fr) * | 2000-06-06 | 2004-05-07 | Sanofi Synthelabo | Propanolaminotetralines, leur preparation et compositions pharmaceutiques en contenant |
| GB0029562D0 (en) | 2000-12-04 | 2001-01-17 | Novartis Ag | Organic compounds |
| US20060052458A1 (en) * | 2003-01-22 | 2006-03-09 | Kissei Pharmaceutical Co., Ltd. | Preventive or remedy for intrauterine late embryonic development or pregnancy toxemia |
| WO2006054514A1 (ja) * | 2004-11-19 | 2006-05-26 | Kissei Pharmaceutical Co., Ltd. | 神経因性疼痛の予防又は治療用医薬組成物 |
| CA2589001A1 (en) * | 2004-11-19 | 2006-05-26 | Kissei Pharmaceutical Co., Ltd. | Preventive or therapeutic agent for neuropathic pain |
| EP2098511A1 (en) | 2008-03-07 | 2009-09-09 | Solvias AG | Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| MX2012005661A (es) * | 2009-11-18 | 2012-09-07 | Medicinova Inc | Tratamiento de exacerbacion aguda de asma y reduccion de probabilidad de hospitalizacion de pacientes que sufren de la misma. |
| US20120035265A1 (en) * | 2010-03-08 | 2012-02-09 | Medicinova, Inc. | Compositions, methods, and devices for the treatment of dysmenorrhea |
| CN102869645A (zh) * | 2010-04-08 | 2013-01-09 | 美迪诺亚公司 | 用于治疗肠易激综合征的方法和组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9107827D0 (en) * | 1991-04-12 | 1991-05-29 | Fujisawa Pharmaceutical Co | New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
| IL104567A (en) * | 1992-02-03 | 1997-03-18 | Fujisawa Pharmaceutical Co | Ethanolamine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same |
| WO1993018007A1 (en) * | 1992-03-13 | 1993-09-16 | Tokyo Tanabe Company Limited | Novel carbostyril derivative |
-
1997
- 1997-02-17 SG SG1997000355A patent/SG72727A1/en unknown
- 1997-02-17 TW TW086102182A patent/TW375604B/zh not_active IP Right Cessation
- 1997-02-18 EA EA199800644A patent/EA002143B1/ru not_active IP Right Cessation
- 1997-02-18 AU AU20014/97A patent/AU725042B2/en not_active Expired
- 1997-02-18 AT AT97902714T patent/ATE225767T1/de active
- 1997-02-18 DE DE69716242T patent/DE69716242T2/de not_active Expired - Lifetime
- 1997-02-18 WO PCT/JP1997/000424 patent/WO1997030023A1/ja active IP Right Grant
- 1997-02-18 EP EP97902714A patent/EP0882704B1/en not_active Expired - Lifetime
- 1997-02-18 CA CA002245490A patent/CA2245490C/en not_active Expired - Lifetime
- 1997-02-18 DK DK97902714T patent/DK0882704T3/da active
- 1997-02-18 MY MYPI97000600A patent/MY123853A/en unknown
- 1997-02-18 CN CN97193866A patent/CN1100032C/zh not_active Expired - Lifetime
- 1997-02-18 PL PL97328530A patent/PL186411B1/pl unknown
- 1997-02-18 PT PT97902714T patent/PT882704E/pt unknown
- 1997-02-18 CZ CZ19982523A patent/CZ293974B6/cs not_active IP Right Cessation
- 1997-02-18 ES ES97902714T patent/ES2184989T3/es not_active Expired - Lifetime
- 1997-02-18 JP JP52920097A patent/JP3892045B2/ja not_active Expired - Lifetime
- 1997-02-18 KR KR10-1998-0706378A patent/KR100491633B1/ko not_active Expired - Lifetime
- 1997-02-18 BR BRPI9707566-3A patent/BR9707566B1/pt not_active IP Right Cessation
- 1997-02-18 HU HU9900621A patent/HU229400B1/hu unknown
- 1997-02-18 US US09/125,429 patent/US6133266A/en not_active Expired - Lifetime
- 1997-02-18 NZ NZ331445A patent/NZ331445A/xx not_active IP Right Cessation
- 1997-02-19 ID IDP970478A patent/ID16091A/id unknown
-
1998
- 1998-08-18 NO NO19983777A patent/NO323095B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID16091A (id) | Turunan 3,4-disubstitusi feniletanolaminotetralin karboksamida | |
| ES2141137T3 (es) | Agentes terapeuticos para la enfermedad de parkinson. | |
| EA200000481A1 (ru) | Производные гидроксамовой кислоты в качестве ингибиторов металлопротеаз матрикса (мпм) | |
| PT93066A (pt) | Processo para a preparacao de derivados heterociclicos contendo nucleos bengenicos fundidos com nucleos monoazotados substituidos e de composicoes farmaceuticas que os contem | |
| EP0640601A4 (en) | Benzamide derivative. | |
| WO1996005166A1 (fr) | Derive d'amine substitue et composition medicamenteuse le contenant | |
| NO913023L (no) | Nye bicykliske aminosubstituerte forbindelser | |
| ATE170851T1 (de) | Guanidinothiazolederivate und ihre anwendung als h2-rezeptor-antagonisten | |
| NO984699L (no) | Fenyletanolamino-tetralinkarboks-amid-derivater | |
| EP0919233B8 (en) | Therapeutic agent for kidney diseases | |
| ES2070962T3 (es) | N-hidroxi-dibenzo(b,e)oxepin-alquilaminas y -amidas de acido alcanoico, compuestos analogos heterociclicos relacionados, un procedimiento para su preparacion y su uso en la preparacion de medicamentos. | |
| CA2251090A1 (en) | Phenylethanolaminotetralincarboxamide derivatives | |
| ES2060056T3 (es) | Derivados de 3-isoxazolonas, su preparacion y su utilizacion en terapeutica. |